Clinical trial
Neoadjuvant or Adjuvant Chemotherapy Without Anthracyclines for Elderly Patients Diagnosed With HER2 Positive Breast Cancer
NCT02102438 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant or Adjuvant Chemotherapy Without Anthracyclines for Elderly Patients Diagnosed With HER2 Positive Breast Cancer
- Lead sponsor
- Instituto do Cancer do Estado de São Paulo
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- April 30, 2014
- Completion date
- April 30, 2018
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, her-2 positive breast cancer